About Deshbhakt Pharma
Deshbhakt Pharma is a Healthcare company. Medicines are manufactured and distributed by Deshbhakt Pharma in the healthcare sector, focusing on affordable and essential pharmaceutical products. Its Indian entity Deshbhakt Pharmaceutical Private Limited reported revenue of ₹1.15 Cr. Deshbhakt Pharma offers products and services including Antihypertensive Medicines and Antidiabetic Medicines. Its focus areas include Pharmaceuticals, Drug Manufacturing, Generic Medicines and Distribution.
Company details
Deshbhakt Pharmaceutical Pvt. Ltd. was established in 2018 to provide high-quality, affordable medicines that address urgent medical needs. A wide range of products, including antihypertensives, antidiabetics, antimicrobials, multivitamins, and parenterals, is sourced from third-party manufacturers and made accessible to citizens. The company is committed to reducing healthcare costs globally while supporting social causes, such as aiding the needy and donating to the Indian Army and martyr families. Efforts are directed towards improving community health through cost-effective solutions.
- SectorsHealthcare
- Email••••••••
- Website deshbhaktpharma.com
- Legal Name Deshbhakt Pharmaceutical Pvt. Ltd
- Date of Incorporation 04 Oct, 2018
- Jurisdiction Nagpur, Maharashtra, India
- Indian entity revenue₹1.15 Cr
FY 2025 · +97% YoY
- Indian entity net loss-₹34.7 Lakh
FY 2025 · -30% margin
- Indian entity EBITDA-₹33.2 Lakh
FY 2025 · -29% margin
Associated legal entities of Deshbhakt Pharma
Deshbhakt Pharma operates through Deshbhakt Pharmaceutical Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Deshbhakt Pharmaceutical Private Limited CIN U74999MH2018PTC315303 | Active | 04 Oct 2018 | Nagpur, Maharashtra | ₹1.1 Cr | 2 | View details |
Products & Services of Deshbhakt Pharma
Deshbhakt Pharma offers a comprehensive portfolio of products and services, including Antihypertensive Medicines and Antidiabetic Medicines.
A range of antihypertensive medicines is manufactured and distributed to manage blood pressure effectively.
Various antidiabetic products are offered to control blood sugar levels and support patient health.
Board of directors of Deshbhakt Pharmaceutical Private Limited (Deshbhakt Pharma)
Deshbhakt Pharmaceutical Private Limited is the primary company behind Deshbhakt Pharma. The board of Deshbhakt Pharmaceutical Private Limited currently have 2 directors; the longest-serving is Ruturaj Rajesh Malani, appointed in 2018. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ruturaj Rajesh Malani DIN 08248726 | Director | 04 Oct 2018 | 8 yrs 1 mo | Deshbhakt Pharmaceutical Private Limited |
| Rajesh Sardarsing Malani DIN 08275432 | Director | 10 Nov 2018 | 8 yrs | Deshbhakt Pharmaceutical Private Limited |
Financials of Deshbhakt Pharma
Figures of Deshbhakt Pharmaceutical Private Limited, the primary company behind Deshbhakt Pharma, for FY 2025. Revenue was ₹1.15 Cr (+97% year on year). Net loss was -₹34.7 Lakh (-30% margin). EBITDA was -₹33.2 Lakh (-29% margin). Revenue has grown at a compounded annual rate of +85% over three years and +28% over five years.
- ₹1.15 CrRevenue · FY 2025 · +97% YoY
- -₹34.7 LakhNet loss · -30% margin
- -₹33.2 LakhEBITDA · -29% margin
- ₹5 LakhPaid-up capital
- +85%Revenue CAGR, 3 years
- +28%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Deshbhakt Pharmaceutical Private Limited are on its company page.
Detailed financial statements for Deshbhakt Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Deshbhakt Pharma
The primary company behind Deshbhakt Pharma, Deshbhakt Pharmaceutical Private Limited, reported revenue of ₹1.15 Cr for FY 2025, up 97% year on year.
Deshbhakt Pharmaceutical Pvt. Ltd. was established in 2018 to provide high-quality, affordable medicines that address urgent medical needs. A wide range of products, including antihypertensives, antidiabetics, antimicrobials, multivitamins, and parenterals, is sourced from third-party manufacturers and made accessible to citizens. The company is committed to reducing healthcare costs globally while supporting social causes, such as aiding the needy and donating to the Indian Army and martyr families. Efforts are directed towards improving community health through cost-effective solutions.
Deshbhakt Pharma offers Antihypertensive Medicines and Antidiabetic Medicines.
Deshbhakt Pharma operates through Deshbhakt Pharmaceutical Private Limited.
The legal entities of Deshbhakt Pharma currently have 2 directors, including Rajesh Sardarsing Malani, Ruturaj Rajesh Malani.